SLN Antikörper
-
- Target Alle SLN Antikörper anzeigen
- SLN (Sarcolipin (SLN))
- Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SLN Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
- Aufreinigung
- Immunogen affinity purified
- Reinheit
- ≥95 % as determined by SDS-PAGE
- Immunogen
- sarcolipin
- Isotyp
- IgG
- Top Product
- Discover our top product SLN Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500-1:1000, IHC: 1:50-1:500, IF: 1:20-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Haltbarkeit
- 12 months
-
- Target
- SLN (Sarcolipin (SLN))
- Andere Bezeichnung
- SLN (SLN Produkte)
- Synonyme
- 2310045A07Rik antikoerper, sarcolipin antikoerper, Sln antikoerper, SLN antikoerper
- Hintergrund
- Synonyms:sarcolipin, SLN Background:Reversibly inhibits the activity of ATP2A1 in sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca(2+). Modulates calcium re-uptake during muscle relaxation and plays an important role in calcium homeostasis in muscle. Required for muscle-based, non-shivering thermogenesis(By similarity).
- Molekulargewicht
- 4 kDa
- Gen-ID
- 6588
- UniProt
- O00631
- Pathways
- Negative Regulation of Transporter Activity
-